Literature DB >> 15658898

Modeling multicellular response to nonuniform distributions of radioactivity: differences in cellular response to self-dose and cross-dose.

Roger W Howell1, Prasad V S V Neti.   

Abstract

Radiopharmaceuticals are distributed nonuniformly in tissue. While distributions of radioactivity often appear uniform at the organ level, in fact, microscopic examination reveals that only a fraction of the cells in tissue are labeled. Labeled cells and unlabeled cells often receive different absorbed doses depending on the extent of the nonuniformity and the characteristics of the emitted radiations. The labeled cells receive an absorbed dose from radioactivity within the cell (self-dose) as well as an absorbed dose from radioactivity in surrounding labeled cells (cross-dose). Unlabeled cells receive only a cross-dose. In recent communications, a multicellular cluster model was used to investigate the lethality of microscopic nonuniform distributions of 131I iododeoxyuridine (131IdU). For a given mean absorbed dose to the tissue, the dose response depended on the percentage of cells that were labeled. Specifically, when 1, 10 and 100% of the cells were labeled, a D37 of 6.4, 5.7 and 4.5 Gy, respectively, was observed. The reason for these differences was recently traced to differences in the cellular response to the self- and cross-doses delivered by 131IdU. Systematic isolation of the effects of self-dose resulted in a D37 of 1.2 +/- 0.3 Gy. The cross-dose component yielded a D37 of 6.4 +/- 0.5 Gy. In the present work, the overall survival of multicellular clusters containing 1, 10 and 100% labeled cells is modeled using a semi-empirical approach that uses the mean lethal self- and cross-doses and the fraction of cells labeled. There is excellent agreement between the theoretical model and the experimental data when the surviving fraction is greater than 1%. Therefore, when the distribution of 131I in tissue is nonuniform at the microscopic level, and the cellular response to self- and cross-doses differs, multicellular dosimetry can be used successfully to predict biological response, whereas the mean absorbed dose fails in this regard.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15658898      PMCID: PMC2933748          DOI: 10.1667/rr3290

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  26 in total

1.  Evidence for pronounced bystander effects caused by nonuniform distributions of radioactivity using a novel three-dimensional tissue culture model.

Authors:  A Bishayee; D V Rao; R W Howell
Journal:  Radiat Res       Date:  1999-07       Impact factor: 2.841

2.  Bystander effects caused by nonuniform distributions of DNA-incorporated (125)I.

Authors:  Roger W Howell; Anupam Bishayee
Journal:  Micron       Date:  2002       Impact factor: 2.251

3.  When may a nonuniform distribution of 131I be considered uniform? An experimental basis for multicellular dosimetry.

Authors:  Prasad V S V Neti; Roger W Howell
Journal:  J Nucl Med       Date:  2003-12       Impact factor: 10.057

Review 4.  Stress signaling from irradiated to non-irradiated cells.

Authors:  E I Azzam; S M de Toledo; J B Little
Journal:  Curr Cancer Drug Targets       Date:  2004-02       Impact factor: 3.428

5.  Calculation of specific energies of incorporated 239Pu and 131I in accordance with the concept of the critical cell.

Authors:  G Tisljar-Lentulis; L E Feinendegen; H Walther
Journal:  Radiat Environ Biophys       Date:  1976-10-07       Impact factor: 1.925

6.  Radiotoxicity of intranuclear tritium, 125 iodine and 131 iodine.

Authors:  K G Hofer; W L Hughes
Journal:  Radiat Res       Date:  1971-07       Impact factor: 2.841

7.  Protection by DMSO against cell death caused by intracellularly localized iodine-125, iodine-131 and polonium-210.

Authors:  A Bishayee; D V Rao; L G Bouchet; W E Bolch; R W Howell
Journal:  Radiat Res       Date:  2000-04       Impact factor: 2.841

8.  Nonuniformity of tumor dose in radioimmunotherapy.

Authors:  J L Humm; L M Cobb
Journal:  J Nucl Med       Date:  1990-01       Impact factor: 10.057

9.  Isolating effects of microscopic nonuniform distributions of (131)I on labeled and unlabeled cells.

Authors:  Prasad V S V Neti; Roger W Howell
Journal:  J Nucl Med       Date:  2004-06       Impact factor: 10.057

10.  Bystander effect produced by radiolabeled tumor cells in vivo.

Authors:  Lanny Y Xue; Nicholas J Butler; G Mike Makrigiorgos; S James Adelstein; Amin I Kassis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205

View more
  8 in total

Review 1.  Challenges and progress in predicting biological responses to incorporated radioactivity.

Authors:  R W Howell; P V S V Neti; M Pinto; B I Gerashchenko; V R Narra; E I Azzam
Journal:  Radiat Prot Dosimetry       Date:  2007-02-06       Impact factor: 0.972

2.  Biological response to nonuniform distributions of (210)Po in multicellular clusters.

Authors:  Prasad V S V Neti; Roger W Howell
Journal:  Radiat Res       Date:  2007-09       Impact factor: 2.841

3.  Survival of tumor and normal cells upon targeting with electron-emitting radionuclides.

Authors:  Didier Rajon; Wesley E Bolch; Roger W Howell
Journal:  Med Phys       Date:  2013-01       Impact factor: 4.071

4.  Flow cytometry-assisted Monte Carlo simulation predicts clonogenic survival of cell populations with lognormal distributions of radiopharmaceuticals and anticancer drugs.

Authors:  John M Akudugu; Roger W Howell
Journal:  Int J Radiat Biol       Date:  2011-12-09       Impact factor: 2.694

5.  Monte Carlo simulation of irradiation and killing in three-dimensional cell populations with lognormal cellular uptake of radioactivity.

Authors:  Roger W Howell; Didier Rajon; Wesley E Bolch
Journal:  Int J Radiat Biol       Date:  2011-11-30       Impact factor: 2.694

6.  Solid-tumor radionuclide therapy dosimetry: new paradigms in view of tumor microenvironment and angiogenesis.

Authors:  Xuping Zhu; Matthew R Palmer; G Mike Makrigiorgos; Amin I Kassis
Journal:  Med Phys       Date:  2010-06       Impact factor: 4.071

7.  Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy.

Authors:  Jörgen Carlsson; Veronika Eriksson; Bo Stenerlöw; Hans Lundqvist
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-23       Impact factor: 9.236

8.  Targeting Micrometastases: The Effect of Heterogeneous Radionuclide Distribution on Tumor Control Probability.

Authors:  Nadia Falzone; Boon Quan Lee; Sarah Able; Javian Malcolm; Samantha Terry; Yasir Alayed; Katherine Anne Vallis
Journal:  J Nucl Med       Date:  2018-06-29       Impact factor: 11.082

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.